BioCryst Pharmaceuticals Inc. has announced new compensation awards for eight recently hired employees. The company granted stock options for a total of 115,000 shares and restricted stock units (RSUs) covering 91,450 shares of BioCryst common stock. The stock options have an exercise price of $7.37 per share, reflecting the closing price on the grant date of October 1, 2025. Both the options and RSUs will vest in four equal annual installments starting one year from the grant date, contingent on continued employment. Each stock option carries a 10-year term.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9539415-en) on October 03, 2025, and is solely responsible for the information contained therein.